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Aim: To assess the frequency of glaucoma-like alterations in Alzheimer’s disease
(AD) patients using Heidelberg Retinal Tomograph III (HRT-3) and Frequency Doubling
Technology (FDT) perimetry.
Methods: The study included 51 eyes of 51 AD subjects and 67 eyes of 67 age- and
sex-matched controls. Subjects underwent an ophthalmological examination including
measurements of intraocular pressure (IOP), Matrix FDT visual field testing, optic nerve
head morphology and retinal nerve fiber layer thickness (RNFLt) assessment by slit-lamp
biomicroscopy and HRT-3.
Results: The frequency of alterations was significantly higher in the AD group (27.5 vs.
7.5%; p = 0.003; OR = 4.69). AD patients showed lower IOP (p = 0.000) despite not
significantly different values of central corneal thickness (CCT) between the groups (p =
0.336). Of all the stereometric parameters measured by HRT-3, RNFLt was significantly
lower in AD patients (p = 0.013). This group also had significantly worse results in terms
of Moorfields Regression Analysis (p = 0.027). Matrix showed significantly worse Mean
Deviation (MD) (p = 0.000) and Pattern Standard Deviation (PSD) (p = 0.000) values
and more altered Glaucoma Hemifield Test (p = 0.006) in AD patients. Pearson’s R
correlation test showed that Mini Mental State Examination is directly correlated with MD
(R = 0.349; p = 0.034) and inversely correlated with PSD (R = −0.357; p = 0.030).
Conclusion: Patients with AD have a higher frequency of glaucoma-like alterations, as
detected by the use of HRT-3. These alterations were not associated with elevated IOP
or abnormal CCT values.
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INTRODUCTION
Glaucoma, the major cause of irreversible blindness worldwide,
is a progressive optic neuropathy associated with degeneration
of retinal ganglion cells (RGCs) and their axons, and it
is characterized by a typical optic nerve appearance and
corresponding visual field loss (European Glaucoma Society,
2008). Until now, increased intraocular pressure (IOP) has
been considered the major treatable risk factor for the disease.
Therefore, despite the relationship between the reduction of IOP
and glaucomatous damage is not yet known, the achievement
of an “individual” target pressure has paramount importance.
However, it has been clinically observed that a significant
reduction of the IOP does not always stop the disease (Leske
et al., 2003). Some patients, in fact, experience a progression of
glaucoma even after a significant reduction of the IOP levels,
whereas others show pathognomonic alterations despite the IOP
is in the normal range.
The exact pathophysiology underlying the glaucoma is
currently unknown. However, studies using magnetic resonance
imaging (MRI) have shown that the disease extends well beyond
the eye, affecting the entire visual pathway, thus suggesting
a possible connection with other neurodegenerative diseases
(Nucci et al., 2013).
Interestingly, clinicians and researchers have observed close
links between glaucoma and Alzheimer’s Disease (AD) (Wostyn
et al., 2009) whose importance is increasing as life-expectancy of
populations rises.
AD is the leading cause of dementia worldwide and is
estimated to affect approximately 50–60% of dementia patients.
The disease is characterized by a gradual, progressive and
irreversible decline in cognitive function and is associated with
certain risk factors, such as genetics and vascular alterations.
The presence of extracellular amyloid-β (Aβ) senile plaques and
the intracellular deposition of abnormally phosphorylated tau
protein are the main hallmarks of the disease (Blennow et al.,
2006).
Although several studies have suggested that there is
no association between glaucoma and an increased risk of
developing AD (Kessing et al., 2007; Bach-Holm et al., 2012;
Ou et al., 2012; Keenan et al., 2014) other population-based
studies have reported a higher prevalence of glaucoma in
patients affected by the disease (Chandra et al., 1986; Bayer
and Ferrari, 2002; Bayer et al., 2002a,b; Tamura et al., 2006;
Lin et al., 2014; Pelletier et al., 2014). These findings have been
supported by data showing that inheritance of the AD-associated
[epsilon]4 allele is twice as high among glaucoma patients,
irrespective of the presence of ocular hypertension (Wostyn et al.,
2009).
These studies may support the hypothesis that, in
some patients, glaucoma could be the expression of a
neurodegenerative process of the central nervous system
that may be only partially influenced by ocular factors, such as
the IOP (Nucci et al., 2013, 2015).
The aim of this study was to evaluate the frequency of
glaucoma-like alterations in a group of patients with AD using
diagnostic criteria based on Frequency Doubling Technology
(FDT) perimetry and Heidelberg Retinal Tomography-3
(HRT-3).
MATERIALS AND METHODS
This study adhered to the Declaration of Helsinki, and the
Institutional Review Boards and Ethics Committees of Tor
Vergata University Hospital approved its protocol.
Written informed consent was obtained from all participants.
The study included 51 consecutive newly diagnosed
Alzheimer’s disease cases (51 eyes), recruited from the
Department of Neurology of Tor Vergata University Hospital.
AD diagnosis was made according to the NINCDS-ADRDA
guidelines and the Diagnostic and the Statistical Manual of
Mental Disorders (DMS IV) (McKhann et al., 1984; American
Psychiatric Association, 2004). All patients underwent a complete
clinical investigation, including medical history, neurological
examination, mini mental state examination (MMSE), a
complete blood screening (including routine exams, thyroid
hormones, level of B12), neuropsychological examination
(Pierantozzi et al., 2004) a complete neuropsychiatric evaluation
and neuroimaging consisting of 1,5 T magnetic resonance
imaging. All the patients were studied for ApoE genotype.
Exclusion criteria were the following: (1) patients with isolated
deficits and /or unmodified MMSE (≥25/30) on revisit (6, 12,
18 months follow-up), patients with clinically manifest acute
stroke in the last 6 months showing an Hachinsky scale >4,
and a radiological evidence of sub-cortical lesions. None of
patients revealed pyramidal and/or extrapyramidal signs at the
neurological examination.
The control group consisted of 67 healthy subjects (67 eyes),
who were randomly recruited from the General Outpatient Clinic
of the Ophthalmological Department of Tor Vergata University
Hospital.
All the enrolled subjects underwent a comprehensive eye
examination, including the determination of best corrected visual
acuity (BCVA) with logarithmic visual acuity charts “ETDRS”
(Precision Vision, la Salle USA), IOP measurement using
Goldmann applanation tonometry, central corneal thickness
(CCT) measurement using an ultrasound pachymeter (Pachette
DGH 500; DGHTechnology, Inc., Philadelphia, PA), gonioscopy,
and slit-lamp biomicroscopy of the anterior and posterior
segments.
Subjects with spherical refraction beyond ±5.0D and/or
cylinder correction beyond ±3.0D, or any ocular or systemic
disease, which could affect the optic nerve or the visual field
examination results, were excluded from the study.
Structural evaluation of the optic disc and retinal nerve
fiber layer (RNFL) were performed using HRT-3 (Heidelberg
Engineering, Heidelberg, Germany), which is a proven tool for
detecting and managing glaucoma, assisting in the identification
of pre-perimetric disease and monitoring of progression. In
all astigmatic eyes beyond ±1.0D, corrective cylindrical lenses
were used. All participants whose tests revealed a Mean Pixel
Height Standard Deviation >30 micron were excluded from the
study. Disc measures of the enrolled patients did not exceed the
database disc area cut-offs provided by the HRT-3 manufacturer.
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(Dascalu et al., 2010) The same operator using only four points
manually traced a contour line around the optic disc edge
(the inner edge of Elschnig’s ring). For each test Moorfields
Regression Analysis (MRA), Glaucoma Probability Score (GPS)
and the following stereometric parameters were evaluated: retinal
nerve fiber layer thickness (RNFLt), Rim Area, Rim Volume,
Cup-Shape Measure (CSM), Height Variation Contour (HVC),
Cup/Disc Ratio (CDR) asymmetry, and vertical Cup/Disc Ratio
(vCDR) (Figure 1).
MRA results, which differentiates abnormal from healthy
optic nerve heads by detecting diffuse and focal changes of the
neuroretinal rim area, were defined as follows: 1=within normal
limits; 2= borderline; 3= outside normal limits.
GPS, which automatically identifies patterns of structural
change consistent with glaucoma providing a probability of
abnormality, was defined as follows: 1 = within normal limits;
2= borderline; 3= outside normal limits; 0= not classified.
The optic disc appearance was also assessed by slit lamp
biomicroscopy examination and defined as pathological when at
least one of the following features was present: vCDR asymmetry
between the eyes ≥0.2, CDR ≥0.5, neuroretinal rim thinning,
splinter-shaped disc hemorrhages, notching, localized pallor,
focal, or generalized peripapillary atrophy or nerve fiber layer
defects, baring of circumlinear or cilioretinal vessels (European
Glaucoma Society, 2008).
Matrix FDT perimetry (Welch Allyn, Skaneateles Falls,
NY, USA and Carl Zeiss Meditec, Dublin, CA, USA) was
obtained from all participants using the 30-2 program. Before
proceeding, all patients received a training and underwent
a pre-test lasting 60 s. The examination was performed on
each eye. Only subjects who performed reliable visual fields
(≤33% fixation losses, false positives, and false negatives) were
included. For each test the following index were evaluated:
mean deviation (MD), pattern standard deviation (PSD), and
glaucoma hemifield test (GHT). MD is a measure of the average
deviation from the patient’s light sensitivity and that of age-
matched controls. PSD shows localized loss of light sensitivity,
which is one of the hallmark of glaucoma. GHT warns the
clinician about the occurrence of significant differences in terms
of clusters of altered points between the superior and inferior
hemifields (Scuderi et al., 2008). GHT results were defined as
follows: 1 = within normal limits; 2 = limit; 3 = borderline;
4 = outside normal limits; 5 = general loss of sensitivity.
The severity of visual field damage was classified according
to the FDT Glaucoma Staging System 2 (GSS2) (Brusini,
2006).
The same operator throughout the whole study performed
all the examinations. For each patient, only the eye with the
worse results in terms of RNFLt, assessed by HRT-3, was included
in the study. Glaucoma-like alterations were defined as the
occurrence of visual field specific defects (GSS2 stage ≥1) and
morphological optic disc alterations at biomicroscopy and/or
pathological changes of HRT-3 parameters.
All data were initially entered into an EXCEL database
(Microsoft, Redmond, Washington—United States) and the
analysis was performed using the Statistical Package for the Social
Sciences, Windows version 19.0 (SPSS, Chicago, Illinois, USA).
Gaussian distributions were differentiated from non-Gaussian
ones by the use of the Kolmogorov-Smirnov test. Descriptive
statistics consisted of the mean ± standard deviation (SD) for
parameters with Gaussian distribution or frequencies (%) for
occurrences. Gaussian parameters were analysed using one-
way ANOVA test. Conversely, non-Gaussian parameters were
analysed using Mann Whitney U or Kolmogorov-Smirnov Z
tests. For categorical variables, comparison of frequencies among
groups was performed using the Chi-Square test or Fisher’s exact
test. Correlations among ocular parameters (MD, PSD, GHT,
MRA, RNFL, IOP) and MMSE were performed using Pearson’s
R correlation test. A p-value < 0.05 was considered statistically
significant.
RESULTS
Descriptive analysis of the AD and Control Groups is shown in
Table 1.
All of the patients resulted E3/E4 in ApoE genotype study.
No significant differences between the groups were found when
considering sex (ANOVA One-way test; p = 0.536) and age
(ANOVA One-way test; p = 0.152).
The frequency distribution of eyes with Matrix visual field
alterations compatible with glaucoma associated with optic disc
damage and/or HRT-3 assessed alterations was significantly
higher in the AD group than in controls (27.5 vs. 7.5%; Chi-
Square test; p = 0.003; OR= 4.69).
Remarkably, the study revealed that the mean IOP values of
the two groups were in the normal range and, more interestingly,
that AD patients had even lower IOP values than controls
(ANOVA one-way test; p = 0.000). Moreover, the analysis of
mean CCT values revealed no statistically significant difference
between the groups (ANOVAOne-way test; p = 0.336) (Table 2)
ensuring an accurate measurement of the IOP.
Comparison of HRT-3 stereometric parameters between the
groups showed significantly reduced RNFLt values (ANOVA
One-way test; p = 0.013) in the AD group (Table 2).
Contrastingly, no significant differences were found when the
following stereometric parameters were considered: Rim area
(ANOVA One-way test; p = 0.271); CSM (ANOVA One-
way test; p = 0.447); HVC (ANOVA One-way test; p =
0.141); Cup/Disc Ratio asymmetry (CDRa) (Mann Whitney U
test; p = 0.399) and vCDR (ANOVA One-way test; p =
0.416). An almost significantly difference was found when
RIM Volume was considered (ANOVA one-way test; p =
0.063). In addition, the statistical analysis, as shown in Table 2,
reveals a significantly worse MRA classification in the AD
group (Mann Whitney U test; p = 0.027), but no significant
differences in terms of GPS score (Mann Whitney U test;
p = 0.208).
When the two global FDT perimetry indices were analysed,
the mean MD values (ANOVA one-way test; p = 0.000)
and mean PSD values (Mann Whitney U test; p = 0.000)
resulted significantly higher in the AD group (Table 2). Finally,
the GHT score was significantly higher in patients with
AD than in controls (Mann Whitney U test; p = 0.006)
(Table 2).
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FIGURE 1 | Heidelberg retinal tomograph III (HRT-3) analisys report.
Correlations among MMSE and ocular parameters (MD,
PSD, GHT, MRA, RNFL, IOP) were performed using Pearson’s
R correlation test. The test showed that Mini Mental State
Examination is directly correlated with MD (R = 0.349; p =
0.034) (Figure 2) and inversely correlated with PSD (R= −0.357;
p = 0.030) (Figure 3).
DISCUSSION
Recent clinical studies have indicated a possible epidemiological
link between glaucoma and AD, suggesting that patients suffering
from the latter have an increased risk of developing glaucoma and
tend to manifest the disease with a more severe clinical picture
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TABLE 1 | Descriptive analysis of the Alzheimer and control groups.
Group Sex Eyes Mean age ± SD Median Min Max MMSE
CTRL M 29 69.9 ± 5.9 70 58 80 –
F 38 68.2 ± 5.9 68 58 80
Total 67 68.9 ± 5.8 69 58 80
AD M 25 69.7 ± 6.6 69 58 80 20.8 ± 4.8
F 26 71.4 ± 5.9 72 58 80 20.8 ± 3.6
Total 51 70.6 ± 6.2 71 58 80
P 0.536a 0.152a
AD, Alzheimer Group; CTRL, Control Group; MMSE, Mini Mental State Examination; SD, standard deviation; p < 0.05.
aANOVA One-way test.
TABLE 2 | Statistical analysis of the ophthalmological parameters
considered.
Variable AD CTRL P
IOP 13.31 ± 2.00 14.81 ± 2.25 0.000a
CCT 538.94 ± 35.34 544.84 ± 30.83 0.336a
RNFL 0.17 ± 0.06 0.20 ± 0.58 0.013a
Rim volume 0.29 ± 0.12 0.33 ± 0.13 0.063a
Rim area 1.35 ± 0.30 1.42 ± 0.35 0.271a
CSM −0.17± 0.13 −0.18± 0.06 0.447a
HVC 0.30 ± 0.08 0.33 ± 0.07 0.141a
vCDR 0.46 ± 0.19 0.43 ± 0.17 0.416a
CDRa 0.07 (0.0; 0.13) 0.05 (0.0; 0.32) 0.339b
MRA 1.6 (1.0; 3.0) 1.3 (1.0; 3.0) 0.027b
GPS 1.0 (1.0; 3.0) 1.0 (1.0; 3.0) 0.208b
MD −6.19± 0.84 −2.82± 0.49 0.000a
PSD 4.66 (1.91; 10.63) 3.03 (0.18; 5.28) 0.000b
GHT 4.0 (1.0: 4.0) 2.0 (1.0; 4.0) 0.006b
Descriptives: Mean± SD for gaussian variables and Median (min.; max.) for non-gaussian
variables. IOP, Intraocular Pressure (mmHg); CCT, Central Corneal Thickness (µm); RNFL,
Retinal Nerve Fiber Layer; CSM, Cup Shape Measure; HVC, Height Variation Contour;
vCDR, Vertical cup/disc ratio; MRA, Moorfields Regression Analysis; GPS, Glaucoma
Probability Score; MD, Mean Deviation; PSD, Pattern Standard Deviation; GHT, Glaucoma
Hemifield Test; CDRa, Cup/Disc Ratio asymmetry; AD, Alzheimer Group; CTRL, Control
Group; p < 0.05.
aANOVA One-way test.
bMann-Whitney U test.
(Bayer and Ferrari, 2002; Bayer et al., 2002a,b; Tamura et al.,
2006; Lin et al., 2014; Pelletier et al., 2014). However, several
studies have produced divergent results (Bach-Holm et al., 2012;
Keenan et al., 2014). It is important to point out that several bias,
such as diagnosis of POAG made by different clinicians using
non-standardized diagnostic criteria, small sample size with wide
confidence limits, affected some of these studies. Unlike previous
reports, in this paper diagnosis of glaucoma was based on the
occurrence of standardized diagnostic criteria, such as typical
visual field defects and optic nerve changes and/or altered HRT-3
parameters.
Patients with cognitive impairment are less likely to produce
reliable visual field test results than healthy subjects do (Trick
FIGURE 2 | Scatter plot of mini mental state examination (mmse) vs.
mean deviation (MD).
et al., 1995). For this reason, previous studies, attempting to
use the Standard Automated Perimetry (SAP) with Humphrey
Field Analyser, have found that a high percentage of patients
could not perform the visual field test. As a result, in those
papers diagnosis of glaucoma relied only on ophthalmoscopic
and stereometric examination of the optic disc. In this study
the analysis of visual field parameters has been assessed by
Matrix FDT, showing typical alterations of glaucoma, such as
worse results in terms of MD, PSD, and GHT, in patients
with AD. In addition, MD and PSD showed, respectively, a
direct and an inverse correlation with MMSE in the presence
of reliable visual field tests. Methodological justification for the
use of Matrix FDT is grounded on its short test duration, on
its reduced “learning effect” on test outcomes, and on Matrix
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FIGURE 3 | Scatter plot of mini mental state examination (mmse) vs.
pattern standard deviation (PSD).
FDT reported ability to identify glaucomatous visual field defects
earlier than SAP (Cello et al., 2000; Pierre-Filho Pde et al.,
2010). Overall, these features make the test more suitable in AD
patients.
Furthermore, in contrast with previous reports (Kurna et al.,
2014) morphological parameters of the optic nerve head and
RNFLt, assessed by a standardized technique such as HRT-3,
demonstrated statistically significant differences between AD and
control group. In particular, in patients with AD, RNFLt was
significantly reduced, and MRA was more frequently altered
compared to controls. Many studies have demonstrated the
ability of HRT to detect early structural alterations of the
optic nerve, achieving results comparable to those obtained by
glaucoma specialists (Deleón-Ortega et al., 2006). Interestingly,
according to the literature, RNFLt is one of the stereometric
parameters best fitting glaucomatous damage and its progression,
showing high sensitivity and specificity (Uchida et al., 1996;
Trick et al., 2006). Moreover, although MRA and GPS have
demonstrated adequate specificity and sensitivity, some discs
cannot be classified using GPS; thus endorsing a greater
usefulness of MRA in glaucoma diagnosis (Andersson et al.,
2011).
In the present paper, we have observed a 27.5% frequency
of glaucoma-like alterations among AD patients, a value five
times higher than in controls. These data strongly support
the hypothesis that a significant percentage of patients with
AD have a clinical picture similar to that found in glaucoma.
Interestingly, we found a statistically significant difference in
the mean IOP between the groups. Besides, AD group showed
IOP values even lower than controls, thus supporting the
hypothesis of an increased susceptibility to the IOP of optic nerve
head of patients with AD. To ensure an accurate evaluation of
the IOP, in contrast to previous studies that never carried out
this test, we measured the CCT values. The analysis of CCT is
of paramount importance because this is an independent risk
factor for developing glaucoma and, even more, is a possible
major source of overestimation (or underestimation) of the
IOP value assessed by applanation tonometry. The finding that
AD patients had CCT values not significantly different from
those of the control population, as well as from the standard,
ensure the absence of any bias in IOP measurement. This is
important because, in our paper, a high proportion of AD
patients presented clinical features similar to those found in
glaucoma, with the exception of ocular hypertension. As a
result, patients with Alzheimer’s disease seem to present a
reduction of the RNFLt and of the rim volume regardless of
the ocular hypertension. It is therefore conceivable that this
reduction could be the result of the extensive central neuronal
loss, typical of Alzheimer’s disease, independent of the IOP,
which could affect the entire visual pathways. Consequently,
in some cases, the clinical picture that we currently define as
glaucoma may actually be the expression of a neurodegenerative
disease of the central nervous system affecting, by transynaptic
degeneration, the entire visual pathway altering the performance
of important vision-related functions and quality of life (Nucci
et al., 2013; Martucci et al., 2014; Cesareo et al., 2015). These
results have been also confirmed by a recent meta-analysis, and
other studies, that reported a significant RNFLt (He et al., 2012;
Marziani et al., 2013) and macular volume reduction, assessed
by optical coherence tomography (OCT), in AD when compared
to healthy subjects (Gao et al., 2015). These data suggest a
possible usefulness of the OCT in diagnosis of neurodegenerative
disease such as AD (Larrosa et al., 2014; Rebolleda et al.,
2015).
The mechanisms underlying the association between AD and
glaucoma are the subject of intense debate in the literature.
Interestingly Wostyn et al. (2009) reported a significant rate
(25%) of very low cerebrospinal fluid pressure (CSFP) values
in AD patients. Incidentally, this percentage is similar to
that of glaucoma-like alterations found in this paper in
AD patients. For anatomical reasons, IOP is counterbalanced
by CSFP and optic nerve tissue pressure from the retro-
laminar regions. It has been hypothesized that a reduction in
CSFP can bring about a displacement of the lamina cribrosa,
resulting in axonal damage at this point. Furthermore, clinical
studies on NTG patients showed a significantly lower CSFP
and a higher trans-lamina cribrosa pressure in these patients
compared to healthy subjects. Therefore, the CSFP reduction
may play a role in the optic nerve damage observed in
patients with AD (Wostyn et al., 2009). This might be a
possible mechanism explaining why, despite significantly lower
IOP values, patients suffering from AD considered in this
study had higher prevalence of glaucoma-like alterations than
controls.
A second hypothesis, which may explain the link between the
two diseases, is that the decrease in production and turnover of
the CSF observed in patients with AD could reduce the clearance
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of toxic substances in the subarachnoid space surrounding
the optic nerve, thus activating neuroinflammatory processes
(Killer et al., 2008; Ho et al., 2012). In this regard, it has
been recently described the case of a glaucoma patient with
medically controlled IOP who experienced a progression of
the disease concomitantly with the onset of mild cognitive
impairment. Interestingly, lumbar puncture revealed decreased
Aβ, and elevated levels of total and phosphorylated tau (Nucci
et al., 2011). It is therefore possible that deposits of tau and/or
other toxic molecules also contributed to development and
progression of glaucoma in patients with AD included in this
study.
The cytotoxic effect of these substances has also been
confirmed at cellular level by studies on autophagy (Hara
et al., 2006; Levine and Kroemer, 2008; Jaeger and Wyss-
Coray, 2010; Wong and Cuervo, 2010; Rodríguez-Muela and
Boya, 2012). A reduction of Beclin-1, a gene product involved
in the initiation and execution of autophagy, has been
reported in AD patients. This seems to be associated with
the accumulation of amyloid precursor protein and Aβ and,
hence, neuronal cell death. In this regard, it has been recently
observed that an acute rise of IOP, reducing Beclin-1, might
derange the retinal autophagic machinery that constitutively
occur in RGCs, causing their death (Russo et al., 2013).
Therefore, all these mechanisms might have contributed to the
morphological and functional damage detected by HRT and
Matrix FDT.
CONCLUSION
In conclusion, our data, collected using objective and
standardized criteria, strongly support a link between AD
and a higher risk of developing glaucoma-like alterations even
without elevated IOP levels. Considering that epidemiological
estimates are forecasting an exponential increase in Alzheimer’s
disease over the next 20 years, there is a risk that in the future we
will face a large number of patients with optic nerve head and
RNFLt alterations linked to this neurodegenerative disease.
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